4.6 Article

Carbapenem-Hydrolyzing GES-5-Encoding Gene on Different Plasmid Types Recovered from a Bacterial Community in a Sewage Treatment Plant

期刊

APPLIED AND ENVIRONMENTAL MICROBIOLOGY
卷 78, 期 4, 页码 1292-1295

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/AEM.06841-11

关键词

-

资金

  1. INSERM, Paris, France [U914]
  2. Ministere de l'Education Nationale et de la Recherche [UPRES-EA3539]
  3. Universite Paris XI, Paris, France
  4. European Community [HEALTH-2009-241742, HEALTH-F3-2008-223031]
  5. European Commission [KBBE-222625]

向作者/读者索取更多资源

Plasmids pRSB113 and pRSB115 were recovered from an activated sludge bacterial community of a municipal wastewater treatment plant in Germany. Both plasmids carry the same bla(GES-5) carbapenemase gene, located within two distinct class 1 integrons. These plasmids have different backbones, belong to different incompatibility groups, and could replicate in both Pseudomonas aeruginosa and Escherichia coli.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales

Remy A. Bonnin, Sandrine Bernabeu, Cecile Emeraud, Thierry Naas, Delphine Girlich, Agnes B. Jousset, Laurent Dortet

Summary: This study demonstrated the high in vitro efficacy of ceftazidime/avibactam, imipenem/relebactam, and to a lesser extent meropenem/vaborbactam against carbapenem-resistant non-carbapenemase-producing Enterobacterales. Testing all beta-lactam/beta-lactamase inhibitor combinations is crucial for carbapenem-resistant Enterobacterales (CRE) as resistance to one combination does not predict resistance to another, depending on the resistance mechanisms involved.

ANTIBIOTICS-BASEL (2023)

Article Microbiology

Emergence of Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae in Switzerland

Otavio Hallal Ferreira Raro, Patrice Nordmann, Manuel Dominguez Pino, Jacqueline Findlay, Laurent Poirel

Summary: There is an increasing occurrence of multidrug-resistant (MDR) and hypervirulent (hv) Klebsiella pneumoniae (MDR-hvKp) convergent clones. These strains can cause difficult-to-treat infections and have a higher mortality rate in healthy adults. This study in Switzerland identified a rate of 9.0% K. pneumoniae with a virulence genotype, producing carbapenemase and recovered from rectal swabs, urine, and blood. The presence of alarming MDR-hvKp and MDR nonhypervirulent K. pneumoniae (MDR-nhv-Kp) isolates highlights the need for surveillance networks to track and monitor their spread.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Infectious Diseases

Resistance to ceftazidime-avibactam in a KPC-2-producing Klebsiella pneumoniae caused by the extended-spectrum beta-lactamase VEB-25

Jacqueline Findlay, Laurent Poirel, Maxime Bouvier, Valeria Gaia, Patrice Nordmann

Summary: Carbapenem-resistant Enterobacterales, including KPC-producing Klebsiella pneumoniae, pose a major threat to public health due to their rapid spread. Ceftazidime-avibactam, a beta-lactam/beta-lactamase inhibitor combination, has shown excellent activity against multidrug-resistant KPC-producing Enterobacterales strains. However, there is an increasing occurrence of CAZ-AVI-resistant K. pneumoniae isolates, mainly due to the emergence of KPC variants that confer resistance to CAZ-AVI but retain carbapenem resistance.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2023)

Article Infectious Diseases

In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates

Christophe Le Terrier, Patrice Nordmann, Mustafa Sadek, Laurent Poirel

Summary: This study evaluated the in vitro activity of cefepime/taniborbactam and cefepime/zidebactam against aztreonam/avibactam-resistant E. coli strains. The results showed that cefepime/taniborbactam had a resistance rate of 100% against these strains, while cefepime/zidebactam was effective in all cases. This suggests that cefepime/zidebactam combination could be a promising therapeutic option.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Microbiology

A Selective Culture Medium for Screening Cefiderocol Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii

Ahmad Ibrahim, Maxime Bouvier, Mustafa Sadek, Jean-Winoc Decousser, Laurent Poirel, Patrice Nordmann

Summary: Cefiderocol (FDC) is an effective siderophore cephalosporin against multidrug-resistant Gram-negative bacteria. The SuperFDC medium was developed to rapidly and accurately identify FDC-resistant pathogens, which is crucial for controlling their spread. The medium showed high sensitivity and specificity in detecting FDC-resistant isolates with various resistance mechanisms.

JOURNAL OF CLINICAL MICROBIOLOGY (2023)

Editorial Material Infectious Diseases

Uncommon close genetic environment responsible for weak expression of blaNDM-1 in Klebsiella pneumoniae of ST147

Delphine Girlich, Cecile Emeraud, Oceane Vanparis, Thierry Naas, Remy A. Bonnin, Laurent Dortet

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2023)

Article Infectious Diseases

Rapid detection of cefiderocol susceptibility/resistance in Acinetobacter baumannii

Otavio Hallal Ferreira Raro, Maxime Bouvier, Auriane Kerbol, Jean-Winoc Decousser, Laurent Poirel, Patrice Nordmann

Summary: The study developed a rapid test for the detection of Acinetobacter baumannii susceptibility to the antibiotic cefiderocol. The test showed high sensitivity and specificity and significantly reduced the time required compared to current methods.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland

Patrice Nordmann, Maxime Bouvier, Laurent Poirel

Summary: Carbapenemase-producing Enterobacterales (CPE) are a major health concern globally, with limited therapeutic options in Switzerland. This study evaluated the susceptibility of CPE isolates recovered in Switzerland from 2018 to 2020 to novel β-lactam/β-lactamase inhibitor combinations, including ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam. The majority of clinical CPE isolates were Klebsiella pneumoniae and Escherichia coli, and the distribution of carbapenemases varied. The study found that meropenem-vaborbactam had the highest susceptibility among the three combinations, followed by ceftazidime-avibactam and imipenem-relebactam. These findings can help optimize first-line therapy for CPE infections.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern

Christophe Le Terrier, Patrice Nordmann, Chloe Buchs, Doris Yoong Wen Di, Gian Maria Rossolini, Roger Stephan, Mariana Castanheira, Laurent Poirel

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Infectious Diseases

Impact of veterinary antibiotics on plasmid-encoded antibiotic resistance transfer

Otavio Hallal Ferreira Raro, Laurent Poirel, Maurine Tocco, Patrice Nordmann

Summary: The study aimed to evaluate whether subdosages of antibiotics administered in veterinary medicine could enhance plasmid transfer and resistance gene exchange in gut microbiota. The results showed that antibiotics in veterinary medicine may induce the transfer of plasmid-encoded resistance and contribute to the global spread of antibiotic resistance genes.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Editorial Material Infectious Diseases

Rapid detection of temocillin resistance in Enterobacterales

Jacqueline Findlay, Laurent Poirel, Patrice Nordmann

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Microbiology

Rapid Aztreonam/Avibactam NP test for detection of aztreonam/avibactam susceptibility/resistance in Enterobacterales

Clement Viguier, Maxime Bouvier, Mustafa Sadek, Auriane Kerbol, Laurent Poirel, Patrice Nordmann

Summary: This study develops a rapid culture-based test for the identification of Aztreonam-avibactam resistance among multidrug-resistant Enterobacterales. The test is rapid, highly sensitive, specific, easily interpretable, and can be easily implemented in routine laboratory practices.

JOURNAL OF CLINICAL MICROBIOLOGY (2023)

Article Microbiology

Uncovering Microbiome Adaptations in a Full-Scale Biogas Plant: Insights from MAG-Centric Metagenomics and Metaproteomics

Julia Hassa, Tom Jonas Tubbesing, Irena Maus, Robert Heyer, Dirk Benndorf, Mathias Effenberger, Christian Henke, Benedikt Osterholz, Michael Beckstette, Alfred Puehler, Alexander Sczyrba, Andreas Schlueter

Summary: This study used metagenomic and metaproteomic analyses to investigate the microbial communities in a full-scale biogas plant with three differently operated digesters. The results showed that these microbial communities had a significant impact on the abundance of enzymes and genes involved in the biogas process, and identified key microorganisms involved in different steps of anaerobic digestion. Further analysis of the highly abundant MAGs in all digesters indicated their potential in ensuring biogas process stability.

MICROORGANISMS (2023)

暂无数据